The novel toluidine sulphonamide EL102 shows pre-clinical in vitro and in vivo activity against prostate cancer and circumvents MDR1 resistance
暂无分享,去创建一个
F. Giles | S. Glynn | J. Lewis | L. Breen | L. Carleton | E. O'Connell | F. Sullivan | A. Gorman | A. Toner | F. McLaughlin | G. Dunne | Gráinne Dunne | Francis J. Giles | Francis J. Sullivan | Enda O’Connell | Laura A. Carleton | Laura Breen | Adrienne M. Gorman | Joe Lewis | Sharon A. Glynn